Literature DB >> 16106056

Function of tumor necrosis factor receptor family members on regulatory T-cells.

Robert H Arch1.   

Abstract

Effector cells play a crucial role in the immune system of higher vertebrates in eliminating invading pathogens and transformed cells that could cause disease or death of the individual. To be effective and specific, immune responses have to distinguish between self and nonself. Mechanisms of central and peripheral tolerance have evolved to control effector cells that could respond to autoantigens. Regulatory T-cells (Treg cells) are critical modulators of effector cells in the periphery that suppress autoreactive T-cells but are also involved in modulating immune responses against invading pathogens. Identification of surface markers of Treg cells and the development of in vitro systems to study the suppressive function of Treg cells have revealed distinct phenotypic and functional subsets of Treg cells. Several tumor necrosis factor receptor (TNFR) family members have been shown to play a role in the development, homeostasis, and suppressor function of Treg cells. Recent findings suggest that TNFRs and other cell-surface molecules of Treg cells can be explored for therapeutic strategies targeting autoimmune disorders, cancer, and immune responses against pathogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16106056     DOI: 10.1385/IR:32:1-3:015

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  127 in total

Review 1.  Thymic selection revisited: how essential is it?

Authors:  Harald von Boehmer; Iannis Aifantis; Fotini Gounari; Orly Azogui; Loralee Haughn; Irina Apostolou; Elmar Jaeckel; Fabio Grassi; Ludger Klein
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

Review 2.  Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells.

Authors:  Françoise Cottrez; Hervé Groux
Journal:  Transplantation       Date:  2004-01-15       Impact factor: 4.939

3.  Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand.

Authors:  B Kwon; K Y Yu; J Ni; G L Yu; I K Jang; Y J Kim; L Xing; D Liu; S X Wang; B S Kwon
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

4.  NOD mice have a generalized defect in their response to transplantation tolerance induction.

Authors:  T G Markees; D V Serreze; N E Phillips; C H Sorli; E J Gordon; L D Shultz; R J Noelle; B A Woda; D L Greiner; J P Mordes; A A Rossini
Journal:  Diabetes       Date:  1999-05       Impact factor: 9.461

5.  TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice.

Authors:  E N Tsitsikov; D Laouini; I F Dunn; T Y Sannikova; L Davidson; F W Alt; R S Geha
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

6.  Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.

Authors:  Chenthamarakshan Vasu; Bellur S Prabhakar; Mark J Holterman
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

Review 7.  Tumor antigens recognized by T lymphocytes.

Authors:  T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Human CD4+CD25+ regulatory T cells share equally complex and comparable repertoires with CD4+CD25- counterparts.

Authors:  Kimberly A Kasow; Xiaohua Chen; James Knowles; David Wichlan; Rupert Handgretinger; Janice M Riberdy
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

9.  Prevention of constitutive TNF receptor 1 signaling by silencer of death domains.

Authors:  Y Jiang; J D Woronicz; W Liu; D V Goeddel
Journal:  Science       Date:  1999-01-22       Impact factor: 47.728

10.  CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.

Authors:  Audrey L Kinter; Margaret Hennessey; Alicia Bell; Sarah Kern; Yin Lin; Marybeth Daucher; Maria Planta; Mary McGlaughlin; Robert Jackson; Steven F Ziegler; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307

View more
  3 in total

Review 1.  Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Int Immunopharmacol       Date:  2011-05-31       Impact factor: 4.932

Review 2.  Regulatory T cell-mediated transplantation tolerance.

Authors:  Ankit Bharat; Ryan Courtney Fields; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Regulation of IL-2 gene expression by Siva and FOXP3 in human T cells.

Authors:  Virginia K Hench; Lishan Su
Journal:  BMC Immunol       Date:  2011-09-28       Impact factor: 3.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.